License Agreements and Litigation: Protecting Your Assets and Revenue Streams in the High-Tech and Life Science Industries
January 21, 2010
The licensing of patents and technology generates valuable revenue for companies and universities. A well-managed licensing program can maximize the value of intellectual property by creating royalty revenue or by leveraging assets to achieve freedom to operate or gain access to the developments of others in creating new products or services. However, pitfalls in the enforcement and defense of licensed patents can be particularly severe and are often overlooked or misunderstood when drafting license agreements.
During Foley’s San Diego Breakfast Briefing we discussed the following topics and key patent licensing considerations:
- The Scope of the License Grant: Who has the right to enforce or defend a licensed patent? What are the potential ramifications for the other party to the license agreement?
- Financial and Business Considerations of Litigating Licensed Patents: Is it best to have one party control the litigation on behalf of the patent holders? What are the financial implications of allocating litigation costs and damages?
- Pursuit of Patent Infringers: How can you avoid declaratory judgment actions brought by a potential infringer and avoid the doctrine of patent exhaustion?
- Licensing Large Patent Portfolios or a Broad Range of Technologies: What are the potential issues in balancing interests between the licensing parties?
Guest Speaker: Carey Fox, Senior VP and General Counsel of Santarus, Inc.
The discussion was led by Foley attorneys:
- Debra D. Nye, Partner, Intellectual Property Litigation, Biotechnology & Pharmaceutical, and Privacy, Security & Information Management Practices.
- David A. Charapp, Special Counsel, Private Equity & Venture Capital and Transactional & Securities Practices.
- Adrian R. Cyhan, Senior Counsel, Intellectual Property Department and Electronics and China Practices.
Related Insights
June 26, 2026
Health Care Law Today
California Attorney General Escalates Attack on PC-MSO Model: What Venture-Backed, Private Equity, and Digital Health Companies Need to Know
Foley & Lardner LLP (Foley) represented Carbon Health in negotiating a settlement agreement with the California Attorney General (AG) to resolve alleged corporate practice of medicine (CPOM) violations against Carbon Health, a technology-based primary and urgent care company that recently emerged from Chapter 11 bankruptcy.
June 26, 2026
Foley Viewpoints
17 States Challenge California Packaging Law With National Supply Chain Stakes
On June 22, 2026, 17 states, led by Nebraska, along with the National Association of Wholesaler-Distributors (NAW), sued California regulators and the Circular Action Alliance (CAA) in federal court, seeking to invalidate the state’s landmark packaging law, SB 54 (“SB 54” or “the Act”). The lawsuit, Nebraska v. Heller, is the first coordinated, multistate attack on the broader “extended producer responsibility” (EPR) model gaining traction for packaging regulation across the United States.
June 25, 2026
Foley Viewpoints
DOJ’s 2026 Health Care Fraud Takedown: Details Behind the Headline Number and What It Means for Health Care Providers
For health care companies, investors, management services organizations, provider platforms, and boards, the more important message is more specific: the government is now treating fast-growing reimbursement categories as data-driven, enterprise-risk environments.